Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt

DOI QR Code

Luca Dell'Angela (Division of Cardiology, Cardio-Thoracic and Vascular Department, Gorizia & Monfalcone Hospital, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI)) ;
Gian Luigi Nicolosi (Department of Cardiology, Policlinico San Giorgio)

Lee OH, Kim JS. Percutaneous patent foramen ovale closure after stroke. Korean Circ J 2022;52:801-7. https://doi.org/10.4070/kcj.2022.0258
Dell'Angela L, Nicolosi GL. Patent foramen ovale closure after cryptogenic stroke: sometimes uncertain benefit maybe, or even potential harm in the long run? J Cardiovasc Med (Hagerstown) 2023;24:381-91. https://doi.org/10.2459/JCM.0000000000001498
Kolokathis K, Thomopoulos C, Tsioufis K. Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: a systematic review and meta-analysis. Hellenic J Cardiol 2023;70:46-52. https://doi.org/10.1016/j.hjc.2022.12.010
Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 2019;40:3182-95. https://doi.org/10.1093/eurheartj/ehy649